Coccidioidal meningitis remains difficult to treat. The newer triazole, isavuconazole, has demonstrated efficacy in invasive fungal disease with less side effects than other azoles. We describe a case of refractory pediatric coccidioidal meningitis with disease stabilization and improvement on isavuconazole after failing treatment with other antifungal agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/INF.0000000000003017 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!